15 April 2020
Visiongain has launched a new pharma report: Biopharmaceuticals Excipients Market 2020-2030: Triglycerides, Esters, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Specialty Biopharmaceutical Excipients & Others.
Pharmaceutical excipients (also known as bulking agent, filler, diluent) are substances formulated with the active ingredient of a drug. They are included in a pharmaceutical dosage form for a special purpose, such as to aid the manufacturing process and to support enhance stability of drugs. Excipients are also useful for product identification and for the enhancement of overall safety and functionality of the product during usage and storage.
The lead analyst of the report commented "Major factors fuelling growth in this market include overall growth in the biopharmaceutical industry and the increasing burden of chronic diseases which surges the demand for innovative and advanced drugs for treatment. The major challenge faced in this industry is the high cost of drug manufacturing, which is compounded by a strict regulatory environment. Government initiatives and increasing research in the development of innovative biopharmaceutical drugs are promising opportunities for market growth."
Leading companies featured in the report include ABITEC Corp, Signet Chemical Corporation, Roquette Freres SA, Sigachi Industries, MEGGLE AG & Other Companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.
16 September 2020
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.
14 September 2020
The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.
09 September 2020
The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.